0000000001302294

AUTHOR

Felicitas Roelofson

showing 2 related works from this author

CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2…

2021

Adjuvant colon cancer (CC) therapy and survival have greatly evolved over the last decades. Research shifted towards a more biological tumour understanding and unlocked new therapies and disease mo...

Oncologymedicine.medical_specialtyColorectal cancerbusiness.industrymedicine.medical_treatmentMEDLINEHematologyGeneral MedicineDiseasemedicine.diseaseCXCR4OncologyInternal medicinePost-hoc analysismedicineRadiology Nuclear Medicine and imagingStage (cooking)businessAdjuvantActa Oncologica
researchProduct

CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2…

2021

CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset

researchProduct